LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Tozasertib | 3.33 | uM | LJP5 | 1 | B14 | 72 | hr | 1209 | 1439 | 3980 | 0.3616 | 0.1064 |
MCF7 | Tozasertib | 3.33 | uM | LJP5 | 2 | B14 | 72 | hr | 1209 | 1442 | 4252 | 0.3391 | 0.1018 |
MCF7 | Tozasertib | 3.33 | uM | LJP5 | 3 | B14 | 72 | hr | 1209 | 1397 | 4376 | 0.3192 | 0.0808 |
MCF7 | Tozasertib | 10 | uM | LJP5 | 1 | B13 | 72 | hr | 1209 | 1335 | 3980 | 0.3354 | 0.0591 |
MCF7 | Tozasertib | 10 | uM | LJP5 | 2 | B13 | 72 | hr | 1209 | 1196 | 4252 | 0.2812 | -0.0062 |
MCF7 | Tozasertib | 10 | uM | LJP5 | 3 | B13 | 72 | hr | 1209 | 1313 | 4376 | 0.3000 | 0.0452 |
MCF7 | Imatinib | 0.04 | uM | LJP6 | 1 | N18 | 72 | hr | 1209 | 3795 | 3823 | 0.9927 | 0.9912 |
MCF7 | Imatinib | 0.04 | uM | LJP6 | 2 | N18 | 72 | hr | 1209 | 3877 | 4093 | 0.9470 | 0.9391 |
MCF7 | Imatinib | 0.04 | uM | LJP6 | 3 | N18 | 72 | hr | 1209 | 3991 | 4121 | 0.9684 | 0.9640 |
MCF7 | Imatinib | 0.12 | uM | LJP6 | 1 | N17 | 72 | hr | 1209 | 3753 | 3823 | 0.9817 | 0.9779 |
MCF7 | Imatinib | 0.12 | uM | LJP6 | 2 | N17 | 72 | hr | 1209 | 4015 | 4093 | 0.9807 | 0.9780 |
MCF7 | Imatinib | 0.12 | uM | LJP6 | 3 | N17 | 72 | hr | 1209 | 4066 | 4121 | 0.9866 | 0.9848 |
MCF7 | Imatinib | 0.37 | uM | LJP6 | 1 | N16 | 72 | hr | 1209 | 3675 | 3823 | 0.9613 | 0.9530 |
MCF7 | Imatinib | 0.37 | uM | LJP6 | 2 | N16 | 72 | hr | 1209 | 4220 | 4093 | 1.0308 | 1.0348 |
MCF7 | Imatinib | 0.37 | uM | LJP6 | 3 | N16 | 72 | hr | 1209 | 4271 | 4121 | 1.0363 | 1.0408 |
MCF7 | Imatinib | 1.11 | uM | LJP6 | 1 | N15 | 72 | hr | 1209 | 4098 | 3823 | 1.0719 | 1.0855 |
MCF7 | Imatinib | 1.11 | uM | LJP6 | 2 | N15 | 72 | hr | 1209 | 3869 | 4093 | 0.9451 | 0.9368 |
MCF7 | Imatinib | 1.11 | uM | LJP6 | 3 | N15 | 72 | hr | 1209 | 4023 | 4121 | 0.9762 | 0.9729 |
MCF7 | Imatinib | 3.33 | uM | LJP6 | 1 | N14 | 72 | hr | 1209 | 3594 | 3823 | 0.9401 | 0.9270 |
MCF7 | Imatinib | 3.33 | uM | LJP6 | 2 | N14 | 72 | hr | 1209 | 3880 | 4093 | 0.9478 | 0.9399 |
MCF7 | Imatinib | 3.33 | uM | LJP6 | 3 | N14 | 72 | hr | 1209 | 4046 | 4121 | 0.9818 | 0.9793 |
MCF7 | Imatinib | 10 | uM | LJP6 | 1 | N13 | 72 | hr | 1209 | 3363 | 3823 | 0.8797 | 0.8514 |
MCF7 | Imatinib | 10 | uM | LJP6 | 2 | N13 | 72 | hr | 1209 | 3571 | 4093 | 0.8723 | 0.8505 |
MCF7 | Imatinib | 10 | uM | LJP6 | 3 | N13 | 72 | hr | 1209 | 3657 | 4121 | 0.8874 | 0.8693 |
MCF7 | NVP-TAE684 | 0.04 | uM | LJP6 | 1 | K18 | 72 | hr | 1209 | 1874 | 3823 | 0.4902 | 0.3018 |